Next Article in Journal
The α-Gal Epitope (Galα1-3Galβ1-4GlcNAc) as Therapeutic Agent in Cancer Immunotherapy, Vaccine Effectiveness Amplification and Injured Tissue Regeneration
Previous Article in Journal
Targeting Neuropeptide Y/DPP4 Signalling Suppresses Ewing Sarcoma Survival and Improves Monocyte Viability
Previous Article in Special Issue
Navigating the Deep Eutectic Solvent Landscape: Experimental and Machine Learning Solubility Explorations of Syringic, p-Coumaric, and Caffeic Acids
 
 
Article

Article Versions Notes

Int. J. Mol. Sci. 2026, 27(6), 2736; https://doi.org/10.3390/ijms27062736
Action Date Notes Link
article html file updated 23 March 2026 10:43 CET Update https://www.mdpi.com/1422-0067/27/6/2736/html
article pdf uploaded. 23 March 2026 10:40 CET Updated version of record https://www.mdpi.com/1422-0067/27/6/2736/pdf
article xml uploaded. 23 March 2026 10:40 CET Update https://www.mdpi.com/1422-0067/27/6/2736/xml
article xml file uploaded 23 March 2026 10:39 CET Update -
article html file updated 19 March 2026 02:08 CET Update -
article html file updated 18 March 2026 11:24 CET Original file -
article pdf uploaded. 18 March 2026 11:19 CET Updated version of record https://www.mdpi.com/1422-0067/27/6/2736/pdf-vor
article xml uploaded. 18 March 2026 11:19 CET Update -
article xml file uploaded 18 March 2026 11:19 CET Original file -
article supplementary file uploaded. 17 March 2026 14:23 CET - https://www.mdpi.com/1422-0067/27/6/2736#supplementary
article pdf uploaded. 17 March 2026 14:23 CET Version of Record https://www.mdpi.com/1422-0067/27/6/2736/pdf-vor
Back to TopTop